JP2024546923A5 - - Google Patents
Info
- Publication number
- JP2024546923A5 JP2024546923A5 JP2024535795A JP2024535795A JP2024546923A5 JP 2024546923 A5 JP2024546923 A5 JP 2024546923A5 JP 2024535795 A JP2024535795 A JP 2024535795A JP 2024535795 A JP2024535795 A JP 2024535795A JP 2024546923 A5 JP2024546923 A5 JP 2024546923A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- scfv
- sequence number
- sequence
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290353P | 2021-12-16 | 2021-12-16 | |
| US63/290,353 | 2021-12-16 | ||
| PCT/US2022/053065 WO2023114430A1 (en) | 2021-12-16 | 2022-12-15 | Manabodies targeting p53 tumor antigens and methods of using |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546923A JP2024546923A (ja) | 2024-12-26 |
| JP2024546923A5 true JP2024546923A5 (https=) | 2025-12-16 |
Family
ID=86773477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535795A Pending JP2024546923A (ja) | 2021-12-16 | 2022-12-15 | Ｐ５３腫瘍抗原を標的とするｍａｎａｂｏｄｙ及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250034252A1 (https=) |
| EP (1) | EP4448583A4 (https=) |
| JP (1) | JP2024546923A (https=) |
| KR (1) | KR20240127981A (https=) |
| CN (1) | CN118541396A (https=) |
| AU (1) | AU2022415459A1 (https=) |
| CA (1) | CA3242393A1 (https=) |
| IL (1) | IL313491A (https=) |
| MX (1) | MX2024007456A (https=) |
| WO (1) | WO2023114430A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106598A1 (en) * | 2023-11-13 | 2025-05-22 | Clasp Therapeutics, Inc. | Modified mana-tces targeting tumor antigens and engaging t cell receptors, and methods of using thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL294183B2 (en) * | 2015-05-20 | 2023-10-01 | Dana Farber Cancer Inst Inc | shared neoantigens |
| GB201617564D0 (en) * | 2016-10-17 | 2016-11-30 | Agency For Science Technology And Research And National University Of Singapore And Singapore Health | Anti-p53 antibodies |
| WO2021127184A1 (en) * | 2019-12-17 | 2021-06-24 | The Johns Hopkins University | MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING |
-
2022
- 2022-12-15 IL IL313491A patent/IL313491A/en unknown
- 2022-12-15 US US18/715,847 patent/US20250034252A1/en active Pending
- 2022-12-15 MX MX2024007456A patent/MX2024007456A/es unknown
- 2022-12-15 CA CA3242393A patent/CA3242393A1/en active Pending
- 2022-12-15 EP EP22908460.3A patent/EP4448583A4/en active Pending
- 2022-12-15 AU AU2022415459A patent/AU2022415459A1/en active Pending
- 2022-12-15 JP JP2024535795A patent/JP2024546923A/ja active Pending
- 2022-12-15 WO PCT/US2022/053065 patent/WO2023114430A1/en not_active Ceased
- 2022-12-15 KR KR1020247021279A patent/KR20240127981A/ko active Pending
- 2022-12-15 CN CN202280087756.7A patent/CN118541396A/zh active Pending